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Abstract 
Data regarding the epidemiology and laboratory test results of end-stage renal disease (ESRD) patients 
on twice per week hemodialysis in Indonesia remain limited. This study was conducted to describe the 
epidemiological and laboratory profiles of ESRD patients undergoing hemodialysis twice a week. This was 
a cross-sectional study in which the medical records data of all ESRD patients on hemodialysis at Cipto 
Mangunkusumo Hospital in 2017. Of 145 subjects, 51% were male. The mean age was 50.1 (SD 13.5) years 
and the mean body mass index (BMI) was 23.1 kg/m2 (SD 4.8). The aetiology of ESRD in these patients 
was primarily hypertension (40.7%). There was a significant difference in systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) before and after hemodialysis (p=0.001 and p<0.001) The mean estimated 
glomerular filtration rate (eGFR) was 4.3 mL/min/1.73 m2 (SD 2.2) and significantly different between those 
<60 years old and ≥60 years old (p=0.004). In addition, there was an association between uric acid and 
post-hemodialysis SBP (p = 0.02). It is concluded that age and sex distribution played a significant role in 
determining epidemiological profile patients undergoing twice per week hemodialysis.
Keywords: epidemiological profile; laboratory profile; twice per week hemodialysis.
Profil Epidemiologi Pasien Hemodialisis Dua Kali per Minggu
di Rumah Sakit Pusat Rujukan Nasional Indonesia
Abstrak 
Data  epidemiologi dan hasil laboratorium pada pasien penyakit ginjal kronik (PGK) stadium akhir 
yang menjalani hemodialisis dua kali per minggu di Indonesia masih terbatas. Studi ini dilakukan untuk 
menggambarkan epidemiologi dan profil laboratorium pasien PGK stadium akhir yang menjalani hemodialisis 
dua kali per minggu.Studi potong lintang ini menggunakan rekam medis seluruh pasien PGK stadium akhir 
yang menjalani hemodialisis di Rumah Sakit Cipto Mangunkusumo pada tahun 2017.  Dari 145 subjek, 51% 
adalah laki-laki. Rerata usia 50,1 tahun (SD 13,5) dan rerata indeks massa tubuh adalah 23,1 kg/m2 (SD 4,8). 
Etiologi PGK stadium akhir didominasi oleh hipertensi (40,7%). Terdapat perbedaan signifikan antara tekanan 
darah sistolik dan diastolik sebelum dan sesudah hemodialisis (p=0.001 dan p<0.001). Rerata laju flitrasi 
glomerulus (LFG) adalah 4,3 mL/min/1,73 m2 (SD 2.2) dan secara signifikan berbeda antara kelompok <60 
tahun dan ≥60 tahun (p=0,004). Selain itu, terdapat hubungan antara asam urat dan tekanan darah sistolik 
pascahemodialisis (p=0,02).  Disimpulkan bahwa usia dan jenis kelamin berperan penting dalam menentukan 
profil epidemiologi pada pasien yang menjalani hemodialisis dua kali per minggu.
Kata kunci: profil epidemiologi; profil laboratorium; hemodialisis dua kali per minggu.
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Introduction
	Chronic	kidney	disease	(CKD)	has	been	defined	
as	a	decrease	in	estimated	glomerular	filtration	rate	
(eGFR) to a level of <60 mL/min/1.73 m2 or evidence 
of albumin excretion or both over a three-month 
period with or without structural changes. An eGFR 
level of less than 15 mL/min/1.73 m2	was	defined	as	
the	final	stage	of	CKD,	called	end-stage	renal	disease	
(ESRD).1 ESRD refers to the kidneys’ inability to 
maintain homeostasis and requires patients to rely 
on a renal replacement therapy (RRT). Hemodialysis 
continues to be the predominant RRT modality in 
Singapore,	 Malaysia,	 Thailand,	 and	 Indonesia.2,3 
The mean global prevalence of CKD based on the 
study by Hill et al.4 was 13.4% for the 44 population 
studies that measured prevalence by all 5 stage 
and 10.6% for the sixty-eight population studies 
measuring stages 3 to 5. 
 The latest data from the Indonesian Renal 
Registry5 showed that 92.1% of 382 renal units in 
Indonesia were in hospital settings and 7.9% were 
in clinics. The highest proportion of ESRD patients 
on hemodialysis in 2015 was in the 45-64 year old 
age	group.	In	2015,	the	financial	source	supporting	
hemodialysis	 patients	 dramatically	 changed,	 with	
the percentage of patients with national health 
insurance	markedly	rising	to	71%.	Hence,	the	total	
proportion of patients on hemodialysis who were 
using the national health insurance system was 
86%. The most common aetiology of renal failure 
in 2015 was hypertensive renal failure (44%).5
 A study by Bae et al.6 showed that survivors of 
hemodialysis were younger than non-survivors (60.2 
years; SD 14.6 vs 64.7 years; SD 14.9; p value<0.001). 
Non-survivors	had	significantly	higher	white	blood	cell	
counts,	as	well	as	lower	albumin	and	serum	creatinine	
levels. Lijie et al7	showed	that	age,	diabetes	mellitus	
(DM)	and	ferritin	were	factors	associated	with	increased	
risk	of	all-cause	mortality,	whereas	BMI,	haemoglobin,	
albumin,	 total	 iron-binding	 capacity	 (TIBC),	 and	
iron were among those that were associated with 
reduced	 risk	 of	 all	 causes	 mortality.	 Therefore,	 this	
study was performed to describe the epidemiological 
and	 laboratory	profiles	of	ESRD	patients	undergoing	
hemodialysis over a one-year period (2017) in a referral 
national government teaching hospital in Indonesia. 
The results were needed to obtain more data for better 
health services and for the formulation of health policy 
and regulations. This study also aimed to explore 
the	 associations	 between	BMI	 and	 total	 cholesterol,	
uric	acid	level	and	blood	pressure,	and	between	total	
cholesterol and blood pressure among hemodialysis 
patients. 
Methods
 This retrospective cross sectional study was 
conducted	in	Dr.	Cipto	Mangunkusumo	National	Central	
Hospital	Jakarta,	also	known	as	Cipto	Mangunkusumo	
Hospital	(CMH).	The	hemodialysis	unit	of	CMH	is	one	
of	the	largest	hemodialysis	units,	serving	as	a	national	
referral hospital for kidney disease patients and not 
only for the population of Jakarta. Every patient in this 
unit undergoes two sessions of approximately 5 hours 
of hemodialysis weekly and has routine laboratory 
tests. Data were collected from medical records over 
a period of one year from 1st January to 31st December 
2017. The inclusion criterion was ESRD patients on 
hemodialysis. 
 Patients with medical records who did not 
have complete or pertinent data were excluded 
from this study. A total of 145 patients had data 
that met the inclusion criterion and were analysed. 
The	 epidemiological	 profile	 included	 gender,	 age,	
hemodialysis	 duration,	 aetiology	 of	 ESRD,	 vascular	
access,	financial	source,	infection	status,	employment	
status,	 origin,	 religion,	 ethnic	 group	 and	 marital	
status.	The	laboratory	profiles	included	haemoglobin,	
haematocrit,	 platelets,	 leukocytes,	 serum	 glutamic	
oxalo-acetic	 transaminase	 (SGOT),	 serum	 glutamic	
pyruvic	 transaminase	 (SGPT),	 total	protein,	albumin,	
globulin,	 serum	 iron,	 TIBC,	 transferrin	 saturation,	
ferritin,	creatinine,	estimated	glomerular	filtration	 rate	
(eGFR),	uric	acid,	triglycerides,	total	cholesterol,	HDL	
cholesterol,	 low	density	 lipoprotein	(LDL)	cholesterol,	
and	 blood	 electrolytes	 (sodium,	 potassium,	 chloride,	
calcium,	and	organic	phosphate).	The	blood	pressures,	
heights and weights of patients were also recorded. 
The study was started after obtaining ethical clearance 
and	administrative	authorization	from	CMH.	
 Data were analysed statistically using SPSS 
version	20.0	(IBM	Corp.,	Armonk,	NY).	The	results	
were	 presented	 as	 numbers	 and	 percentages,	
means	and	standard	deviations,	and	medians.	For	
the	 analytical	 tests,	we	 used	 the	 chi	 square	 test,	
dependent	t-test,	Mann-Whitney	test,	and	ANOVA.	
P	values	of	<0.05	were	considered	significant.
Ethics Approval and Consent  to Participate
The protocol of this study was approved by 
the	 Health	 Research	 Ethics	 Committee,	 Faculty	 of	
Medicine,	Universitas	Indonesia	with	ethical	approval	
reference	 number	 0370/UN2.F1/ETIK/	 2018	 and	
protocol number 18-04-0451. This study only used 
secondary data which was hemodialysis patient’s 
medical record and had no treatment or contact with 
patients.	Therefore,	 informed	 consent	 to	 participate	
was not obtained in this study. All of data gained 
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from medical records were stored at Hemodialysis 
Unit	of	Cipto	Mangunkusumo	Hospital	to	preserve	its	
confidentiality.		
Results
Epidemiological Profile of Participants
	As	seen	in	Table	1,	there	were	145	hemodialysis	
patients. The overall mean age of patients was 50.1 
years	(SD	13.5).	Total	mean	age	at	first	hemodialysis	
was	44.2	years	(SD	14.0)	and	there	was	no	significant	
difference	in	current	age	or	age	at	first	hemodialysis	
between males and females (p-value 0.319 and 
0.379).	 Significantly	 (p-value	 <0.001)	 more	 males	
were employed (54.1%) than females and there 
were more patients who were married than who were 
unmarried. The patients were most likely to receive 
hemodialysis for 1-4 years (71 patients) and most 
of the hemodialysis costs were funded by national 
health insurance. The majority of the patients were 
from	Jakarta.	The	mean	BMI	was	23.1	(SD	4.8)	and	
BMI	did	not	differ	 significantly	between	males	and	
females (p-value 0.205). The aetiologies of ESRD 
were mostly hypertension (40.5% of males and 
40.8% of females) and glomerulonephritis (32.4% of 
males and 25.4% of females). The most common 
vascular access in these hemodialysis patients was 
via	 the	 arteriovenous	 (AV)	 fistula.	 	 Most	 of	 these	
patients did not have infections.
Overall Laboratory Profile of Participants and 
by Gender and Age
	As	 seen	 in	 Table	 2,	 there	 was	 a	 significant	
difference in both mean systolic blood pressure 
(SBP) and diastolic blood pressure (DBP) before and 
after hemodialysis (pre vs post SBP p-value 0.001 
and pre vs post DBP p-value <0.001). The overall 
mean values of SBP pre- and post-hemodialysis 
were 147.9 mmHg (SD 27.0) and 141.4 mmHg 
(SD	 30.1),	 while	 the	 overall	 mean	 DBP	 values	
pre- and post-hemodialysis were 79.1 mmHg (SD 
15.4)	and	80.1	mmHg	(SD	17.1).	Mean	SBP	before	
hemodialysis was higher than after hemodialysis for 
both	genders	and	in	all	age	groups.	In	contrast,	the	
DBP values increased after hemodialysis for both 
genders and all age groups. There were significant 
mean differences in DBP pre-hemodialysis and 
post-hemodialysis in both age groups with a p-value 
of 0.004 for DBP pre-hemodialysis and a p-value of 
0.018 for DBP post-hemodialysis.
The mean haemoglobin concentration was 9.9 
g/dL (SD 1.76). The mean haematocrit was 29.9% 
(SD 5.6) and was higher in males (30.1%; SD 5.7) 
and in the <60 years age group (mean 30.0%; 
SD	5.7).	The	mean	platelet	count	was	223,910.3/
µL	 (SD	66,727.8),	 and	was	 significantly	 higher	 in	
males.	The	mean	leukocyte	count	was	7,900/µl	(SD	
2,600).	The	mean	leukocyte	count		in	the	<60	years	
age	 group	 (7,990.9/µl;	 SD	 2,744.5)	 was	 higher	
than	 that	 in	 the	≥60	years	age	group	 (7,658.9/µl;	
SD	 2,137.4).	 There	 was	 a	 significant	 difference	
in creatinine levels between the male and female 
groups	 and	between	 the	<60	and	 ≥60	 years	 age	
groups (p-value <0.001). The mean eGFR was 4.3 
mL/min/1.73 m2 (SD 2.2) and was higher in females 
(4.5 mL/min/1.73 m2;	 SD	 1.5)	 and	 significantly	
different	between	the	<60	and	≥60	age	groups.
The mean total protein levels in females (7.4 
g/dL; SD 0.9) and in the <60 years age group (7.3 
g/dL; SD 0.8) were higher than those in the male 
group	 (7.2	 g/dL:	 SD	 0.6)	 and	 the	 ≥60	 years	 age	
group (7.1 g/dL; SD 0.9). The overall mean albumin 
level	was	4.0	g/dL	(SD	0.80)	and	was	significantly	
higher in the <60 years age group. 
Total cholesterol and HDL cholesterol were 
significantly	 higher	 in	 females	 (p-value	 <0.001).	
The mean ferritin serum (556.1 ng/mL; SD 593.5) 
and	uric	acid	 (10.9	mg/dL,	SD	18.0)	 levels	were	
higher	 in	 females,	 and	 the	 mean	 uric	 acid	 was	
significantly	higher	in	the	<60	years	age	group	(11	
mg/dL,	SD	16	mg/dL;	p-value	<0.001).	The	mean	
triglyceride levels were higher in females and the 
≥60	years	age	group.
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Table 1. Epidemiological Profiles of the Patients
Variables Overall Male Female p-Value
n (%) 145 (100) 74 (51) 71 (49) -
Mean	age		in	years	(SD) 50.12 (13.49) 49.03 (13.38) 51.27 (13.6) 0.319
Age,	min-max,	year 18-79 18-78 18-79 -
Median	age	(25-75th	percentiles),	years 52 50.50 52 -
Mean	age	at	first	hemodialysis	years(SD) 44.9 (14) 43.91 (13.4) 45.9 (14.7) 0.379
Age	at	first	hemodialysis,	min-max,	 16-79 16-76 16-79 -
Median	age	at	first	hemodialysis	(25-75th	percentiles),	years 45 44 46 -
Employment	status,	n	(%) <0.001
Employed 51 (35.2) 40 (54.1) 11 (15.5)
Unemployed 94 (64.8) 34 (45.9) 60 (84.5)
Marital	status,	n	(%) 0.070
Married 134 (92.4) 65 (87.8) 69 (97.2)
Unmarried	 11 (7.6) 9 (12.2) 2 (2.8)
Treatment	period,	n	(%) 0.962
< 1 year 13 (9.0) 6 (8.1) 7 (9.9)
1-4 years 71 (49) 37 (50) 34 (47.9)
5-10 years 40 (27.6) 21 (28.4) 19 (26.8)
>10 years 21 (14.5) 10 (13.5) 11 (15.5)
Financial	source,	n	(%) 0.490
JKN/BPJS 144 (99.3) 74 (100) 70 (98.6)
Private Insurance 1 (0.7) 0 (0) 1 (1.4)
Origin,	n	(%) 0.153
Jakarta 101 (69.7) 56 (75.7) 45 (63.4)
Outside Jakarta 44 (30.3) 18 (24.3) 26 (36.6)
Religion,	n	(%) -
Islam 134 (92.4) 65 (87.8) 69 (97.2)
Christian 10 (6.9) 8 (10.8) 2 (2.8)
Buddhist 1 (0.7) 1 (1.4)
Ethnicity,	n	(%) -
Javanese 67 (46.2) 31 (41.9) 36 (50.7)
Betawinese 26 (17.9) 12 (16.2) 14 (19.7)
Sundanese 25 (17.2) 16 (21.6) 9 (12.7)
Others 27 (18.6) 15 (20.3) 12 (16.9)
BMI	mean	(SD) 23.1 (4.8) 22.6 (4.8) 23.6 (4.7) 0.205
Aetiology	of	ESRD,	n	(%) 0.664
Hypertension 59 (40.7) 30 (40.5) 29 (40.8)
Glomerulonephritis 37 (25.5) 21 (28.4) 16 (22.5)
Diabetes	Mellitus 36 (24.8) 16 (21.6) 20 (28.2)
Others 12 (8.3) 6 (8.1) 6 (8.5)
Unknown 1 (0.7) 1 (1.4) -
Vascular	access,	n	(%) 0.401
Fistula	AV	(Cimino) 84 (57.9) 43 (58.1) 41 (57.7)
Tunnel Catheter 49 (33.8) 27 (36.5) 22 (31)
Femoral 12 (8.3) 4 (5.4) 8 (11.3)
Infection	status,	n	(%) 0.537
No Infection 78 (53.8) 40 (54.1) 38 (53.5)
Hepatitis B 5 (3.4) 4 (5.4) 1 (1.4)
Hepatitis C 58 (40) 29 (39.2) 29 (40.8)
Hepatitis B and C 3 (2.1) 1 (1.4) 2 (2.8)
Hepatitis	C	and	HIV 1 (0.7) - 1 (1.4)
Systolic	blood	pressure,	n	(%)
Pre-hemodialysis -
<140 mmHg 49 (33.8) 23 (31.1) 26 (36.6)
≥140	mmHg 96 (66.2) 51 (68.9) 45 (63.4)
Post-hemodialysis -
<140 mmHg 65 (44.8) 33 (44.6) 32 (45.1)
≥140	mmHg 80 (55.2) 41 (55.4) 39 (54.9)
Diastolic	blood	pressure,	n	(%)
Pre-hemodialysis -
<90 mmHg 106 (73.1) 51 (68.9) 55 (77.5)
≥90	mmHg 39 (26.9) 23 (31.1) 16 (22.5)
Pre-hemodialysis -
<90 mmHg 102 (70.3) 48 (64.9) 54 (76.1)
≥90	mmHg 43 (29.7) 26 (35.1) 17 (23.9)
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Table 2. Distribution of Laboratory Profiles of Patients According to Age and Gender
Parameter
Overall Mean (SD)
Gender
Mean (SD)
P-Value
Age 
Mean (SD)
P-Value
Men
n = 74
Women
n = 71
<60 years
n =108
≥60 years
n = 37
Systolic blood pressure
Pre-hemodialysis (mmHg) 147.9 (27.0) 151.0 (27.0) 144.7 (26.8) 0.166 147.0 (27.4) 150.5  (25.9) 0.495
Post-hemodialysis (mmHg) 141.46 (30.1) 144.1 (31.9) 138.6 (28.1) 0.267 140.4 (30.4) 144.5 (29.5) 0.472
Diastolic blood pressure
Pre-hemodialysis (mmHg) 79.1 (15.4) 80.8 (16.3) 77.3 (14.2) 0.178 81.2 (15.2) 72.8 (14.2) 0.004
Post-hemodialysis (mmHg) 80.1 (17.1) 81.7 (14.6) 78.35 (19.2) 0.234 82.0 (17.6) 74.3 (14.1) 0.018
Haemoglobin 9.9 (1.7) 10 (1.7) 9.7 (1.7) 0.255 9.9 (1.8) 9.7 (1.6) 0.554
Haematocrit 29.9 (5.5) 30.1 (5.7) 29.7 (5.4) 0.663 30.0 (5.7) 29.6 (5.0) 0.685
Platelets 223910.3 (66727.8)
204891.8 
(52929.1)
243732.3 
(73872.8) <0.001
225425.9 
(70179.1)
219486.4 
(56079.6) 0.642
Leukocyte 7900 (2600) 7500 (2100) 8200 (3000) 0.334 7900 (2700) 7600 (2100) 0.502
Creatinine 12.1 (4) 13.7 (4.1) 10.4 (3.1) <0.001 13.1 (3.7) 9.2 (3.4) <0.001
eGFR 4.3 (2.2) 4.1 (1.5) 4.5 (2.7) 0.583 3.9 (1.6) 5.3 (3.1) 0.004
Blood urea nitrogen 139.8 (43.4) 147.5 (45.3) 131.8 (40.1) 0.029 143.3 (43.8) 129.7 (41.2) 0.103
Total Protein 12.1 (4.0) 7.2 (0.6) 7.4 (0.9) 0.579 7.3 (0.8) 7.1 (0.9) 0.440
Albumin 4 (0.8) 4 (0.9) 3.9 (0.6) 0.73 4 (0.8) 3.9 (0.8) 0.035
Globulin 3.2 (0.7) 3.2 (0.6) 3.3 (0.8) 0.561 3.2 (0.6) 3.3 (0.8) 0.828
SGOT 20.2 (16.4) 17.6 (12.5) 22.9 (19.4) 0.148 19 (16.2) 23.6 (16.9) 0.094
SGPT 19.3 (20) 19.3 (19) 19.3 (21.2) 0.585 18.6 (18.8) 21.3 (23.4) 0.897
Calcium 9.8 (8.7) 8.9 (1) 10.9 (12.3) 0.421 10.3 (10.0) 8.7 (1.8) 0.993
Phosphorus 5.9 (3.3) 5.8 (2.1) 6.1 (4.3) 0.624 6 (2.2) 5.8 (5.5) 0.034
Potassium 4.6 (0.8) 4.5 (0.8) 4.6 (0.8) 0.676 4.6 (0.8) 4.5 (0.9) 0.623
Sodium 138.3 (12.8) 139.2 (7.7) 137.3 (16.5) 0.252 137.9 (14.6) 139.4 (4.3) 0.721
Chloride 98 (15.3) 99 (21) 97 (4.7) 0.815 98 (17.5) 98.0 (4.9) 0.205
Glucose,	mg/dl 124.7 (85.3) 116. 9 (77.4) 132.9 (92.7) 0.141 114.2 (74.2) 155.3 (107) 0.024
Serum iron 62.7 (25.6) 63.2 (25.2) 62.2 (26.2) 0.859 62.1 (26.9) 64.5 (21.5) 0.215
TIBC 216.7 (52.1) 220.8 (52.5) 212.4 (51.7) 0.604 214.8 (51.5) 222.3 (54.4) 0.388
Transferrin saturation 29.7 (13.9) 29.7 (13.5) 29.8 (14.4) 0.851 29.1 (12.8) 31.6 (16.8) 0.686
Ferritin serum 485.9 (561.9) 418.5 (524.9) 556.1(593.5) 0.021 489.3 (561.3) 475.9 (571.2) 0.991
Total	cholesterol,	mg/dl 164.6 (40.6) 153 (36.1) 176.7 (41.7) <0.001 161.7 (36.7) 173.1 (49.9) 0.206
HDL	cholesterol,	mg/dl 36.7 (12.3) 32.5 (11) 41.2 (12.2) <0.001 35.9 (11.4) 39.1 ± (14.6) 0.227
LDL	cholesterol,	mg/dl 104.8 (33.6) 98.3 (32.3) 111.5 (33.8) 0.025 103.4 (31.2) 108.7 (39.9) 0.637
Triglycerides,	mg/dl 156.3 (122.4) 148.8 (140) 164 (101.2) 0.121 145 (73.6) 189.1 (205.8) 0.281
Uric	acid 10 (13.9) 9 (8.1) 10.9 (18) 0.791 11 (16) 7 (1.4) <0.001
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Association between BMI and Total Cholesterol
As	seen	in	Table	3,	120	(82.8%)	hemodialysis	
patients had normal total cholesterol. The highest 
number of hemodialysis patients with normal and 
high total cholesterol was found in patients with 
normal	BMI.	 In	 contrast,	 patients	who	 had	 normal	
total cholesterol levels were more likely to be obese 
than	overweight	or	underweight.	BMI	of	hemodialysis	
patients	did	not	have	a	significant	association	with	
total cholesterol levels (p-value 0.479).
Table 3. Association of Body Mass Index and Total Cholesterol
BMI Classification
Total Cholesterol Category
p valueNormal High Total
n (%) n (%) n (%)
Underweight 17 (77.3) 5 (22.7) 22 (100)
0.479
Normal 47 (83.9) 9 (16.1) 56 (100)
Overweight 18 (75) 6 (25) 24 (100)
Obese 38 (88.4) 5 (11.6) 43 (100)
Total 120 (82.8) 25 (17.2) 145 (100)
Association of Uric Acid and Blood Pressure
	As	 seen	 in	Table	 4,	 normal	 or	 high	 uric	 acid	
levels were more likely in patients who had pre-
hemodialysis SBP levels falling within the stage 
2 hypertension category. Levels of uric acid had 
no	 significant	 association	 with	 pre-hemodialysis	
SBP (p-value 0.426). Normal or high uric acid 
levels were seen in patients with pre-hemodialysis 
DBP levels falling within the stage 2 hypertension 
category.	Uric	acid	levels	did	not	have	a	significant	
association with pre-hemodialysis DBP (p-value 
0.964). Patients with high uric acid had higher post-
hemodialysis	SBP,	with	only	29.4%	showing	normal	
post-hemodialysis	 SBP,	 and	 uric	 acid	 levels	 had	
a	 significant	 association	 with	 post-hemodialysis	
SBP (p-value 0.02). Patients with high uric acid 
levels were more likely to have a normal post-
hemodialysis	DBP	(50%),	as	the	uric	acid	level	was	
not shown to be statistically associated with the 
post-hemodialysis DBP
Table 4. Association of Uric Acid and Blood Pressure
Uric Acid
Normal Pre-Hypertension
Stage 1 
Hypertension
Stage 2 
Hypertension Total p value
n % n % n % n % n %
Pre-Hemodialysis Systolic Blood Pressure
Normal 6 14 5 11.6 11 25.6 21 48.8 43 100 0.426
High 19 18.6 19 18.6 32 31.4 32 31.4 102 100
Total 25 17.2 24 16.6 43 29.7 53 36.6 145 100
Pre-Hemodialysis Diastolic Blood Pressure
Normal 6 14 5 11.6 11 25.6 21 48.8 43 100 0.964
High 19 18.6 19 18.6 32 31.4 32 31.4 102 100
Total 25 17.2 24 16.6 43 29.7 53 36.6 145 100
Post-Hemodialysis Systolic Blood Pressure
Normal 7 16.3 10 23.3 6 14 20 46.5 43 100 0.02
High 30 29.4 18 17.6 29 28.4 25 24.5 102 100
Total 31 25.5 28 19.3 35 24.1 45 31 145 100
Post-Hemodialysis Diastolic Blood Pressure
Normal 17 39.5 9 20.9 13 30.2 4 9.3 43 100 0.253
High 51 50 25 24.5 16 15.7 10 9.8 102 100
Total 68 46.9 34 23.4 29 20 14 9.7 145 100
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Association of Total Cholesterol and Blood 
Pressure
As	 seen	 in	 Table	 5,	 normal	 and	 high	 total	
cholesterol were mostly observed in patients with pre-
hemodialysis SBP levels at stage 2. A bivariate analysis 
was	 performed	 and	 found	 no	 significant	 association	
between cholesterol levels and pre-hemodialysis SBP. 
High total cholesterol was more commonly seen in 
patients	who	had	normal	pre-hemodialysis	DBP	(40%),	
but total cholesterol was not associated with pre-
hemodialysis DBP (p-value 0.826). High cholesterol 
was seen in patients who had post-hemodialysis SBP 
levels in the category of stage 2 hypertension (40%). 
Total	 cholesterol	 did	 not	 correlate	 significantly	 with	
post-hemodialysis SBP. High cholesterol was mostly 
observed in patients with normal blood pressure (36%). 
Total	cholesterol	was	not	significantly	associated	with	
post-hemodialysis DBP.
Table 5. Association of Total Cholesterol and Blood Pressure
Total 
Cholesterol
Normal Pre-Hypertension
Stage 1 
Hypertension
Stage 2 
Hypertension Total p 
value
n % n % n % n % n %
Pre-Hemodialysis Systolic Blood Pressure
Normal 22 18.3 20 16.7 34 28.3 44 36.7 120 100 0.826
High 3 12 4 16 9 36 9 36 25 100
Total 25 17.2 24 16.6 43 29.7 53 36.6 145 100
Pre-Hemodialysis Diastolic Blood Pressure
Normal 63 52.5 26 21.7 18 15 13 10.8 120 100 0.536
High 10 40 7 28 6 24 2 8 25 100
Total 73 50.3 33 22.8 24 16.6 15 10.3 145 100
Post-Hemodialysis Systolic Blood Pressure
Normal 34 28.3 23 19.2 28 23.3 35 29.2 120 100 0.371
High 3 12 5 20 7 28 10 40 25 100
Total 37 25.5 28 19.3 35 24.1 45 31 145 100
Post-Hemodialysis Diastolic Blood Pressure
Normal 59 49.2 27 22.5 24 20 10 8.3 120 100 0.514
High 9 36 7 28 5 20 4 16 25 100
Total 68 46.9 34 23.4 29 20 14 9.7 145 100
Discussion
 The results of this study regarding proportion 
of	 male	 patients,	 employment	 status,	 and	
hypertension as most frequent aetiology of ESRD 
were in line with those of Halle et al.8	Most	male	
patients who participated in this study were the 
family	 financial	 surety/insurer.	 The	mean	 age	 of	
participants in the present study was similar to 
that	of	participants	in	the	Vijayalaksmi	et	al.9 study 
in India (50.1 years; SD 13.4 vs 53.5 years; SD 
14.5).	 In	 addition,	 that	 study	 also	 showed	 that	
there	were	significant	differences	in	the	mean	SBP	
and DBP values between males and females and 
that	 there	 was	 a	 significant	 difference	 in	 serum	
creatinine and urea levels between males and 
females.9 The main aetiology of ESRD found in 
this study contrasted with that found in data from 
developed countries. According to data from the 
US	 Renal	 Data	 System	 2014	 cited	 by	 National	
Center for Chronic Disease Prevention and Health 
Promotion,10 the primary causes of ESRD in the 
United	 States	 were	 diabetes	 (44%	 of	 cases	 in	
2014 and 37.47% of cases in 2015) followed by 
hypertension/high blood pressure (29% of cases 
in 2014 and 25.1% cases in 2015). 
	This	 study	 showed	 that	 the	 AV	 fistula	 was	
the most frequently used vascular access in 
hemodialysis	 patients	 at	 CMH.	 The	 ANSWER11 
study in Spain also showed that 52% of all patients 
had	 an	 AV	 fistula	 as	 their	 vascular	 access	 for	
hemodialysis. Other vascular access points used 
by	 hemodialysis	 patients	 at	 CMH	 were	 femoral	
and tunnel catheter. The usage of femoral vascular 
access	 in	 hemodialysis	 practice	 at	 CMH	 was	
because	 some	 patients	 could	 not	 receive	 an	AV	
fistula	and	had	difficulty	using	the	tunnel	catheter.
 Caetano et al.12	 suggested	 that	 a	 high	 BMI	
between 25 and 29.9 kg/m2, and	 even	 a	 BMI	
in the range of morbid obesity (>35 kg/m2),	
showed a protective effect for survival of patients 
who	 underwent	 hemodialysis.	 In	 other	 words,	
higher	 BMI	 was	 associated	 with	 better	 survival	
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compared	normal	BMI,	 a	 reverse	epidemiological	
phenomenon.	 In	 contrast,	 the	 mean	 BMI	 of	
hemodialysis patients in this study was 23.1 kg/
m2	(SD	4.8),	which	is	still	considered	in	the	normal	
BMI	range.	Therefore,	 further	study	regarding	 the	
association	between	BMI	and	survival	among	 the	
participants	 of	 this	 study	 is	 needed,	 as	 BMI	 has	
shown a reverse epidemiological phenomenon. 
	In	this	study,	the	overall	mean	haematocrit	was	
<33%. A clinical review by Fishbane et al.13 showed 
that a haematocrit of <33% was associated with 
decreased eGFR (<30 mL/min/1.73 m2 in women 
and <20 mL/min/1.73 m2 in men). Supporting this 
evidence,	we	showed	that	 the	eGFR	in	both	men	
(4.1 mL/min/1.73 m2; SD 1.5) and women (4.5 mL/
min/1.73 m2; SD 2.7) was lower than the threshold 
in the above mentioned review.
 The mean eGFR in the group of patients <60 
years	 in	 age	 was	 significantly	 lower	 than	 that	 of	
patients	≥60	years	old.	The	serum	creatinine	 level	
of	the	patients	<60	years	old	was	significantly	lower	
than	 that	 of	 the	≥60	 years	old	group.	We	showed	
that the residual renal function of the younger age 
group	was	worse	than	that	of	the	older	age	group,	a	
finding	supported	by	a	study	by	Vijayalakshmi	et	al.9
 Contrary to a clinical review by Daugirdas et al.14 
which stated that platelet number was potentially 
reduced in hemodialysis patients to the range of 
175-180,000/µL,	we	showed	that	the	mean	platelet	
count of all patients was at a higher level than the 
range	mentioned	earlier	(223,910/µL).
	 In	this	study,	the	mean	leukocyte	count	of	all	
patients	was	7,900/µl	(SD	2,600/µl).	This	result	was	
somewhat similar to that for all patients in a study 
by Sibarani et al.15	(mean	leukocyte	count	of	7,883/
µl	(SD	3,494)).	We	showed	that	the	male	group	had	
lower	leukocyte	counts	than	the	female	group,	and	
this result was contrary to the results of Fan et al.16 
which showed that men were more likely to have 
higher leukocyte counts.
This study showed that serum total protein in 
women	and	in	those	<60	years	old	was	significantly	
higher	than	in	men	and	those	≥60	years	old.	However,	
studies have suggested that plasma protein cannot 
be	used	as	a	 single	 criterion	 for	 nutritional	 status,	
due	 to	 other	 contributing	 factors	 including	 age,	
comorbidities,	hypervolemia,	and	weight	loss.16
The mean SGOT and SGPT were in normal 
value	 ranges	 (as	 seen	 in	 Table	 3),	 a	 result	
supported by Hou et al.17 who reported that there 
was no observed impairment in the liver function of 
hemodialysis patients.
Electrolytes	 are	 important	 laboratory	 profile	
measures associated with risk of mortality in 
hemodialysis patients.17 The mean potassium level 
of all patients in this study was more than 4 mEq/L 
(4.62	mEq/L;	SD	0.84),	considered	in	the	safe	level	
range (as seen in Table 3); a study by Korgaonkar et 
al.18 reported that serum potassium levels of 3.5-4 
mEq/L were associated with higher risk of mortality. 
The mean sodium level of all patients in this study 
was in the normal range of 135-145 mEq/L; low 
sodium levels were associated with higher risk of 
mortality according to a study by Sun et al.19
In	 terms	of	 lipid	profiles,	we	reported	that	 the	
female	 group	 had	 significantly	 higher	 levels	 of	
cholesterol	(LDL,	HDL,	and	total)	and	triglycerides	
than the male group. A similar result was reported 
by Bashardoust et al.20 The normal range of chloride 
levels	at	CMH	is	94—111	mEq/L	(as	seen	in	Table	
3).	 In	 this	 study,	 the	 mean	 chloride	 level	 of	 all	
patients was in the normal range. Hypochloraemia 
was associated with cardiovascular risk and 
mortality	in	patients	with	CKD,	according	to	a	study	
by	Mandai	et	al.21 
The mean blood glucose of all patients in this 
study (124.7 mg/dL; SD 85.3) was better than 
that observed in a study by Osonoi et al.22 who 
reported a mean blood glucose of 138.7 mg/dL 
(SD 35.3). This result indicates that there is good 
blood glucose control in patients on hemodialysis 
at	CMH,	specifically	 in	patients	who	had	diabetes	
mellitus (24.8%).
In	the	present	study,	the	mean	uric	acid	level	of	
all patients was higher than that reported in a study 
by Chang et al.23 who found mean uric acid levels 
of	6.2	mg/dL	(SD	1.54).	Contrary	to	popular	theory,	
and to the results from Chang et al.23 who reported 
that	 females	 had	 significantly	 lower	 levels	 of	 uric	
acid	than	males,	we	showed	that	the	female	group	
had	significantly	higher	levels	of	uric	acid.	However,	
higher levels of uric acid are associated with a lower 
risk of cardiovascular mortality in hemodialysis 
patients,	according	to	a	study	by	Latif	et	al.24
Anaemia is common in patients with ESRD. 
One of the indicators of anaemia in ESRD patients 
in addition to hemoglobin is the TIBC level. A study 
by Bross et al.25 reported a mean TIBC level of 208 
mg/dL	 (SD	 40).	 We	 showed	 a	 higher	 result,	 with	
a mean TIBC of 216.7 mg/dL (SD 52.1). Reduced 
TIBC	levels	have	been	significantly	associated	with	
increased risk of mortality in hemodialysis patients.25
 Chertow et al.26 reported that serum 
albumin was a potent predictor of mortality and 
cardiovascular	events	in	patients	with	ESRD,	while	
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higher serum albumin was related to a decrease 
in the risk of access-related hospitalization. In 
addition,	 advanced	 age,	 lower	 body	weight,	 lower	
haemoglobin,	 and	 higher	 ferritin	 were	 predictors	
of	 all-cause	 hospitalization,	 whereas	 older	 age,	
higher	 concentration	 of	 phosphorus,	 calcium,	 and	
ferritin were among the predictors of cardiovascular 
hospitalization. The results of this study showed that 
mean albumin and calcium levels were considered 
normal,	mean	phosphorus	and	 ferritin	were	higher	
than	the	normal	range,	and	mean	albumin	was	lower	
than	 the	 normal	 range	 in	 our	 patients.	 Therefore,	
hemodialysis and health care providers need to be 
aware of the future cardiovascular hospitalization 
possibility.	 In	 addition,	 the	 mean	 haemoglobin	
in	 this	 study	 was	 considered	 lower	 than	 normal,	
even	 though	erythropoietin	at	a	2	x	3000	 IU	dose	
was given to all patients except those with certain 
conditions.  
 The mean SBP values before and after 
hemodialysis in this study were 147.9 mmHg (SD 
27.0)	and	141.4	mmHg	 (SD	30.1),	while	 the	pre-	
and post-hemodialysis DBP values were 79.10 
mmHg (SD 15.4) and 80.1 mmHg (SD 17.1). 
According to Turner et al.27 and Port et al.28 both 
mean pre- and post-hemodialysis SBP values were 
in	 the	safe	 range,	because	an	SBP	of	more	 than	
135 mmHg before and after dialysis was found to 
be	a	protective	factor,	but	an	SBP	of	less	than	130	
mmHg or more than 160 mmHg increased the risk 
of	mortality.	We	showed	that	the	pre-hemodialysis	
SBP was higher than the post-hemodialysis SBP. 
This could be explained by studies that showed 
that hemodialysis reduced SBP by decreasing 
plasma volume.29 The mean DBP of patients in this 
study increased after hemodialysis. This result was 
similar	to	that	of	Yang	et	al.30 although the increase 
of	DBP	observed	in	that	study	was	not	significant.	
Strengths and Limitations of This Study
 A limitation of this study was the cross-sectional 
design,	which	did	not	explain	the	causal	relationships	
among two or more variables but showed only the 
association	 of	 the	 variables.	 However,	 this	 study	
presented	not	only	the	epidemiological	profiles	but	
also the laboratory results from a major referral 
national government teaching hospital in Jakarta. 
To	the	best	of	our	knowledge,	this	was	the	first	such	
study	in	Indonesia,	particularly	in	Jakarta.	
Conclusions
 Patients with ESRD undergoing hemodialysis 
were mostly middle-aged males who were 
employed	and	married.	Most	of	the	hemodialysis	
costs were funded by National Health Insurance 
Programme. Hypertension was the most common 
aetiology in these populations. Patients were 
mostly	 from	 Jakarta	 and	 Java.	 Vascular	 access	
was	most	 frequently	 achieved	 via	 the	AV	 fistula	
followed by tunnel catheter and femoral access. 
In	addition,	more	than	half	of	the	subjects	did	not	
have any infection. 
There	were	significant	differences	in	both	SBP	
and DBP before and after hemodialysis in both 
genders.	The	mean	albumin,	calcium,	haemoglobin,	
and haematocrit levels of participants were in the 
normal	range,	while	the	mean	levels	of	phosphorus	
and	ferritin	were	higher	than	normal	values.		 W e	
also found that there were associations between 
uric	 acid	 and	 post-hemodialysis	 SBP,	 but	 we	 did	
not	 find	 any	 associations	 between	 BMI	 and	 total	
cholesterol,	between	total	cholesterol	and	all	blood	
pressure variables (pre-/post-SBP and pre-/post-
DBP),	or	between	uric	acid	and	pre-hemodialysis	
SBP or pre-/post-hemodialysis DBP.
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